Levofloxacin Noridem

Levofloxacin, the active ingredient in Levofloxacin Noridem, is a fluoroquinolone presented as an intravenous solution for intravenous use. It treats a range of serious bacterial infections, including community‑acquired pneumonia, complicated urinary tract infections, skin and soft‑tissue infections, intra‑abdominal infections and bacterial prostatitis in adult patients.\n\nGNH India supplies Levofloxacin Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution. Customers benefit from reliable logistics and responsive technical support.

Levofloxacin is a fluoroquinolone antibiotic indicated for several serious bacterial infections.\n\nCommunity‑acquired pneumonia: effective bacterial eradication leading to clinical cure.\nComplicated urinary tract infections: provides effective elimination of uropathogens and resolution of infection.\nSkin and soft‑tissue infections: reduces bacterial load and promotes healing of infected lesions.\nIntra‑abdominal infections: targets mixed aerobic and anaerobic organisms to restore abdominal health.\nBacterial prostatitis: penetrates prostatic tissue to eradicate causative bacteria and improve symptoms.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.\n\nCommon Side Effects:\n- Nausea: mild gastrointestinal upset.\n- Diarrhea: loose stools, often self‑limiting.\n- Headache: transient cranial discomfort.\n- Dizziness: sensation of light‑headedness.\n- Rash: mild skin erythema.\n- Insomnia: difficulty initiating sleep.\n\nSerious or Rare Side Effects:\n- Tendon rupture: especially Achilles tendon, may occur during or after therapy.\n- QT interval prolongation: can precipitate cardiac arrhythmias.\n- Clostridioides difficile infection: severe colitis following disruption of gut flora.\n- Severe hypersensitivity reactions: including Stevens‑Johnson syndrome or anaphylaxis.\n- Hepatic dysfunction: elevated liver enzymes or hepatitis.\n- Seizures: central nervous system excitation, particularly in patients with renal impairment.

When prescribing Levofloxacin, clinicians should consider several safety precautions to minimize risk.\n- Renal impairment: assess kidney function and adjust dose as needed.\n- History of tendon disorders: avoid use in patients with prior tendon injury or tendonitis.\n- QT prolongation risk: monitor ECG in patients with cardiac disease or on other QT‑prolonging drugs.\n- Pregnancy Category C: prescribe only when potential benefits justify potential fetal risk.\n- Concomitant antacids containing aluminum or magnesium: separate administration by at least two hours to ensure absorption.\n- Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Levofloxacin interacts with several medicines; awareness of these interactions helps prevent adverse outcomes.\n\nMajor Interactions (Avoid):\n- Warfarin: may increase INR and bleeding risk.\n- Theophylline: can raise serum theophylline concentrations, leading to toxicity.\n- Ciprofloxacin or other fluoroquinolones: additive QT prolongation.\n- NSAIDs (e.g., ibuprofen, naproxen): heightened risk of central nervous system stimulation and seizures.\n\nModerate Interactions (Monitor Closely):\n- Antacids with aluminum or magnesium: reduce levofloxacin absorption; separate dosing.\n- Diabetes medications (insulin, sulfonylureas): may alter glucose control.\n- Cyclosporine: levofloxacin can increase cyclosporine levels, requiring monitoring.